Build by AI

The Great AI Pivot: When Cybersecurity Becomes Currency I 18th April

Share episode

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 29:07
Companies are abandoning moonshots for hard cash, governments are weaponizing security concerns, and everyone's scrambling to prove they're the 'safe' AI choice. Today we dive into Anthropic's sudden cybersecurity pivot after months of White House drama, OpenAI's brutal shutdown of Sora and its entire science team, and why a code editor might be worth more than most countries' GDP. Plus: biotech gets its own GPT model and design tools that could put Figma on notice.
SPEAKER_01

Okay, so let me get this straight. Anthropic spent two months fighting with the Trump administration, and now suddenly they're like, hey, we've got this amazing cybersecurity model that'll solve all your problems. That's not suspicious timing at all.

SPEAKER_00

Dude, it's like watching a kid who got sent to the principal's office suddenly volunteer to be hall monitor. But here's the thing: this whole dance between AI companies and the government, it's becoming the new reality. Security concerns are basically the new regulatory currency.

SPEAKER_01

And meanwhile, OpenAI is just torching everything. Sora's gone, the science team's gone, Kevin Weil's out the door. It's like they looked at their entire consumer strategy and said, nah, enterprise money only please.

SPEAKER_00

Right. And that tells you everything about where this industry is heading. The moonshot era, it's over. Welcome to the Show Me the Revenue era.

SPEAKER_01

But wait, it gets weirder. While everyone's pivoting to boring enterprise stuff, a code editor just raised money at a$50 billion valuation.$50 billion. That's like saying VS Code could buy Disney.

SPEAKER_00

Okay. That cursor valuation is absolutely insane. And we need to talk about whether we're in another tech bubble because those numbers are making my head spin. But first, the government drama, because that's reshaping everything.

SPEAKER_01

You're listening to Build by AI. I'm Alex Shannon. And what we just described there, that's not even the wildest part of today's AI news.

SPEAKER_00

And uh I'm Sam Hinton. We've got companies pivoting so hard they're getting whiplash, valuations that would make crypto blush, and oh yeah, um, your biotech researchers just got their own personal AI assistant. Buckle up.

SPEAKER_01

Plus, we're going to dig into why AI companies are suddenly obsessed with being the safe choice, what it means when the government starts treating AI like a national security issue, and whether all this enterprise focus is actually good for innovation, or if we're about to enter the most boring era of AI development ever.

SPEAKER_00

Spoiler alert, it's probably both. The technology is getting more useful and way less exciting at the same time, but hey, that's what maturation looks like in tech.

SPEAKER_01

Alright, let's dive in. So let's start with this Anthropic story because the optics here are just fascinating. After nearly two months of being in what sources are calling conflict with the Trump administration, Anthropic is now developing a cybersecurity-focused AI model. And conveniently, this could help repair their relationship with the government.

SPEAKER_00

And honestly, it's probably gonna work.

SPEAKER_01

But what was the original conflict about? We don't have the full details, but given the timing and the solution they're proposing, I'm guessing it was around safety concerns or regulatory compliance. What do you think?

SPEAKER_00

Oh, absolutely. Look, every AI company right now is playing this delicate game where they need to appear cooperative with government oversight while still pushing the boundaries of what's possible. Anthropic probably pushed a little too hard on the we know what we're doing, trust us angle.

SPEAKER_01

Right, and now they're pivoting to actually we're your best friends in the cybersecurity space. But here's my question: is this a genuine strategic shift, or is this just telling the government what it wants to hear?

SPEAKER_00

Honestly, probably both. Cybersecurity is a massive market opportunity, and we're talking hundreds of billions of dollars. Plus, if you can position yourself as the AI company that helps the government defend against other AI threats, that's like the ultimate moat.

SPEAKER_01

That's a really good point. It's almost like saying we're not just another AI company you need to regulate. We're the AI company that helps you regulate everyone else. That's a completely different conversation.

SPEAKER_00

Exactly. And think about the timing here. We're seeing more and more AI-powered cyber attacks, nation-state actors using AI for espionage, deepfakes being used for social engineering. The government is probably desperate for allies in this space.

SPEAKER_01

But here's what I'm wondering. If Anthropic succeeds with this strategy, doesn't that create pressure for OpenAI, Google, everyone else to also pivot toward government-friendly applications? Like, could we see a whole industry shift toward AI for national security?

SPEAKER_00

Oh, a hundred percent. This could be the template. Going forward, instead of competing on pure capability or consumer features, companies compete on how aligned they are with government priorities. That's a huge shift in competitive dynamics.

SPEAKER_01

And the implications for innovation are interesting too. Because government priorities don't always align with what's technically most impressive or what consumers actually want. We could see the industry optimize for different things entirely.

SPEAKER_00

Yeah, but maybe that's not entirely bad. Like, if the choices between AI companies optimizing for viral demos versus optimizing for actual security and reliability, I'd probably choose the latter.

SPEAKER_01

That's fair. And from a business perspective, government contracts are typically much more stable and lucrative than consumer subscriptions. If you can land a multi-year cybersecurity deal with a federal agency, that's predictable revenue in a way that consumer AI just isn't.

SPEAKER_00

Plus, think about the expertise required. Cybersecurity AI isn't just about making a chatbot that can write better phishing emails. You need deep domain knowledge, understanding of threat landscapes, integration with existing security infrastructure. That's a real technical challenge.

SPEAKER_01

Right, so this isn't just corporate positioning. It's potentially a genuine technical pivot, which makes me more optimistic about it, honestly. If Anthropic is serious about building cybersecurity-specific capabilities that could produce some genuinely useful tools.

SPEAKER_00

And for anyone listening who works in cybersecurity or adjacent fields, this could be huge. If Anthropic succeeds in positioning Claude as the go-to cybersecurity AI, that changes the competitive landscape completely. Keep an eye on how this relationship develops because it could set the template for how other AI companies navigate government relations going forward.

SPEAKER_01

Absolutely. And I suspect we're going to see more White House meetings, more congressional hearings, more of this public-private partnership approach to AI development. The days of tech companies operating in complete independence from government oversight are definitely over.

SPEAKER_00

Which honestly might be overdue. AI is too important and too potentially dangerous to develop in a regulatory vacuum. Even if it slows things down a bit, having government input on AI development priorities is probably necessary at this point.

SPEAKER_01

Alright, so moving on to some pretty dramatic news from OpenAI. Kevin Weil and Bill Peebles are both leaving the company. And more significantly, OpenAI is shutting down Sora, their video generation model, and folding their entire science team. This is being framed as a shift away from consumer moonshot projects toward enterprise AI.

SPEAKER_00

Dude, this is brutal. Sora was supposed to be their big consumer play, their look how cool AI can be moment. And now they're just done? That tells me the enterprise money is so good that they're willing to abandon everything else.

SPEAKER_01

But wait, Kevin Weil was pretty senior there, right? He came from Twitter, had a lot of product experience. When people like that start leaving, especially during what seems like a major strategic pivot, that raises some questions for me.

SPEAKER_00

Oh yeah, absolutely. Look, there's probably two things happening here. One, the easy venture money is gone. Investors want to see actual revenue, not just cool demos. And two, the competition in consumer AI is insane right now. Why why fight that battle when enterprises are literally throwing money at you?

SPEAKER_01

Okay, but hold on, let's think about what this means for innovation. Sora was genuinely impressive technology. Are we entering this phase where companies only build things that have immediate commercial applications? Because that feels like we might be losing something important.

SPEAKER_00

That's the trade-off, right? Um the moonshot era was fun, but it was also financially unsustainable for most companies. I mean, how long can you burn cash on projects that might pay off someday when there's guaranteed enterprise revenue sitting right there?

SPEAKER_01

I get the business logic, I really do. But part of me worries that this shift toward enterprise-first development means we're going to see less of the breakthrough paradigm shifting stuff and more of the makes quarterly numbers look good stuff.

SPEAKER_00

Yeah, but here's the counter-argument. Maybe focusing on real business problems actually leads to better AI. Instead of building cool demos that don't solve actual problems, companies are now forced to build things that work in the real world at scale, reliably.

SPEAKER_01

That's a good point, but I'm still hung up on the human cost here. Bill Peebles was doing really interesting work on the science side, and now that whole team is gone. What happens to that research? Does it just disappear, or does it get folded into enterprise products?

SPEAKER_00

Probably a bit of both. The practical stuff gets repurposed for enterprise applications and the more experimental research just stops, which is sad from a scientific perspective. But that's capitalism for you.

SPEAKER_01

And what about the competitive implications? If open AI is abandoning consumer AI, doesn't that create a huge opportunity for someone else? Like Sora was genuinely ahead of most video generation tools.

SPEAKER_00

Oh, absolutely. You know, this is basically open AI saying we're ceding the consumer video market to whoever wants it. That could be a massive opportunity for startups or even other big players like Google or Meta.

SPEAKER_01

But maybe that's the smart play. Instead of trying to be everything to everyone, open AI is focusing on what makes them the most money with the least competition. From a business strategy perspective, it's probably the right move.

SPEAKER_00

Yeah, and and let's be real about the consumer AI market right now. It's crowded, it's competitive, and most importantly, it's really hard to monetize. How do you charge consumers enough for AI tools to justify the compute costs? It's a tough equation.

SPEAKER_01

Whereas enterprise customers will happily pay thousands of dollars per month for AI tools that save their employees time or improve productivity. The unit economics are just completely different.

SPEAKER_00

Exactly. And enterprise customers also tend to be stickier. Once you integrate an AI tool into your business workflows, switching costs are high. That's the kind of recurring revenue that makes investors happy.

SPEAKER_01

So for anyone working in enterprise technology or considering AI implementations at their company, this is probably good news. More focused development, more reliable products, better support. It's just the end of an era, you know? Better.

SPEAKER_00

Totally. The move fast and break things era of AI is officially over. Welcome to the show-me the ROI era. But honestly, the technology is mature enough now that maybe that's exactly what we need.

SPEAKER_01

Rather than just building flashy new capabilities that don't solve real problems, that could actually be better for everyone in the long run.

SPEAKER_00

Plus, let's not forget that enterprise AI is still pretty early stage. There's so much opportunity to improve productivity, automate workflows, augment human capabilities in business contexts. That's not boring work, it's just more practical than generating videos of cats.

SPEAKER_01

Speaking of OpenAI pivoting towards specific use cases, they've launched something called GPT Rosalind, which is a specialized AI model designed specifically for the biotech industry. And I love that they named it after Rosalind Franklin, by the way.

SPEAKER_00

Oh, that's a great name choice. And this fits perfectly with what we were just talking about. Instead of building general purpose tools, they're building domain-specific solutions. Biotech is a massive industry with very specific needs that general AI models probably struggle with.

SPEAKER_01

Right. And think about the complexity there. Biotech professionals are dealing with protein structures, drug interactions, clinical trial data, regulatory requirements. A general model trained on the entire internet probably isn't going to understand the nuances of, say, FDA approval processes.

SPEAKER_00

Exactly. And this is where the real money is going to be made in AI, not in replacing human creativity or whatever, but in augmenting highly skilled professionals in complex domains, a biotech researcher who can work twice as fast because they have an AI assistant that actually understands their field. That's worth serious money.

SPEAKER_01

But I'm curious about the training data here. Biotech research is often proprietary, heavily regulated, sometimes confidential. How do you train an AI model on that kind of information without running into legal or ethical issues?

SPEAKER_00

That's a great question. They're probably using publicly available research papers, FDA databases, published clinical trial results. But you're right that the really valuable stuff is probably locked away in corporate databases that OpenAI doesn't have access to.

SPEAKER_01

Which could actually be an opportunity for partnerships. Like imagine if OpenAI worked with major pharmaceutical companies to create custom models trained on their proprietary data. That could be incredibly valuable for drug discovery.

SPEAKER_00

Oh man, that's a huge market. Drug discovery is notoriously expensive and time-consuming. If AI can accelerate any part of that process, target identification, compound screening, trial design, that's potentially billions of dollars in value.

SPEAKER_01

But I'm curious about the competitive dynamics here. Biotech is traditionally a pretty conservative industry. Are they ready to integrate AI tools into their workflows, especially for something as critical as drug development?

SPEAKER_00

That's the million-dollar question, literally. But I think the pressure is there. Drug development costs are insane, timelines are getting longer, and there's this growing sense that AI could help speed things up. Plus, if your competitors are using AI and you're not good point.

SPEAKER_01

And the regulatory environment is actually starting to catch up too. The FDA has been pretty proactive about creating frameworks for AI-assisted drug development, so the pieces are falling into place. That's interesting, the grant writing angle. Academic researchers spend so much time writing proposals instead of doing actual research. If AI can help streamline that process, that frees up more time for the actual science.

SPEAKER_00

Totally. And biotech is is one of those fields where small improvements in efficiency can have massive downstream effects. If you can identify promising drug targets 20% faster, that could translate to life-saving treatments reaching patients months or years earlier.

SPEAKER_01

Which brings up an interesting ethical dimension too. If AI can genuinely accelerate medical research, is there almost a moral obligation to adopt these tools? The faster we can develop new treatments, the more lives we can potentially save.

SPEAKER_00

It's not just about business efficiency, it's about human impact, and that might help overcome some of the traditional conservatism in the biotech industry.

SPEAKER_01

Yeah, and think about the applications. You could use this for literature review, hypothesis generation, experimental design, data analysis. Any biotech professional listening to this should probably be looking into how tools like this could fit into their workflow.

SPEAKER_00

Absolutely. And this is probably just the beginning. I expect we'll see domain-specific AI models for law, finance, engineering, maybe even creative fields. The age of one size fits all AI is ending, and honestly, that's probably a good thing.

SPEAKER_01

It also opens up interesting questions about specialization versus generalization in AI development. Are we going to see companies focus on becoming the definitive AI solution for specific industries, or will there still be value in general purpose models?

SPEAKER_00

Probably both, right? You need the general foundation, but then you specialize on top of that. It's like how you have general programming languages, but then domain-specific frameworks built on top of them.

SPEAKER_01

And staying on this theme of specialized AI tools, Anthropic just launched something called Clawed Design, which helps non-designers, think founders, product managers, people like that, create quick visuals without needing design expertise.

SPEAKER_00

Okay, this is interesting because it's basically Anthropic saying we see your mid-journey in Dolly, but we're going after the business market. This isn't about creating art, it's about creating presentations and mock-ups and marketing materials.

SPEAKER_01

Right, and that makes total sense for their brand positioning. They've always been the responsible AI for business company. But I'm wondering, how does this compete with existing design tools? Like where does this sit versus Canva or Figma or even just hiring a designer?

SPEAKER_00

Aaron Powell I think it's targeting a different use case entirely. You know, this is for the founder who needs a quick mock-up for a pitch deck at 11 p.m., or the product manager who who wants to visualize an idea without waiting for the design team. It's about speed and accessibility, not replacing professional designers.

SPEAKER_01

That's smart positioning. But I have to ask, are we creating a world where everyone thinks they're a designer just because they have AI tools? Because we've seen what happens when everyone thinks they're a photographer because they have Instagram filters.

SPEAKER_00

Ha. Okay, but here's the thing. Maybe that's not entirely bad. Like, if a startup founder can create decent looking materials without spending thousands on a designer in the early stages, that lowers the barrier to entrepreneurship, the professional designers will still have jobs doing the sophisticated stuff.

SPEAKER_01

Fair point. And realistically, the kind of person who's going to use clawed design probably wasn't going to hire a professional designer anyway. They were going to use PowerPoint clip art or something equally tragic.

SPEAKER_00

Exactly. So this is probably net positive for the world's visual aesthetics. Plus, think about the workflow integration possibilities. If this works well with other business tools, it could become one of those features that people don't realize they need until they have it.

SPEAKER_01

But I'm curious about the quality threshold here. Business visuals need to look professional, but they don't need to be groundbreaking creative work. Can AI hit that sweet spot of good enough for a board presentation consistently?

SPEAKER_00

Oh, that's probably the key question. If Claud Design can consistently produce materials that look professional and on-brand, that's hugely valuable. If it's hit or miss, people will try it once and then go back to hiring humans.

SPEAKER_01

And there's the brand consistency angle too. Most businesses have specific color schemes, fonts, logo usage guidelines. Can an AI tool understand and apply those constraints while still being creative within those boundaries?

SPEAKER_00

That's actually where AI could really shine. Once you train it on a company's brand guidelines, it could potentially apply those rules more consistently than a human designer who might forget the exact specifications.

SPEAKER_01

Good point. And think about the iteration speed. If you can generate multiple design options instantly, that changes the entire creative process. Instead of waiting days for a designer to create options, you can explore ideas in real time.

SPEAKER_00

Yeah, and that could actually improve the final output. More iteration usually leads to better results. But it's traditionally been constrained by time and budget. If AI removes those constraints, we might see better design overall.

SPEAKER_01

Although let's be honest about the competitive implications for Canva here, they've built this massive business around making design accessible to non-designers. If AI can do that even more effectively, Canva might have a problem.

SPEAKER_00

True. But Canva's not stupid. They're probably working on their own AI features. The question is whether they can integrate AI into their existing platform effectively, or if new AI-first tools like Cloud Design have an advantage.

SPEAKER_01

And for anyone listening who runs a small business or startup, this could be genuinely useful. The ability to quickly create professional-looking visuals without learning complex design software or hiring expensive freelancers. That's real value right there.

SPEAKER_00

Absolutely. AI for sales presentations, AI for HR materials, AI for marketing campaigns. It's about making professional quality work accessible to everyone.

SPEAKER_01

Which ties back to our bigger theme today. AI companies are getting really focused on specific, valuable use cases instead of trying to build general-purpose everything tools. Clawed design is a perfect example of that trend. Alright, time for some rapid fire. First up, and this is still early reporting, so take it with appropriate skepticism, but Cursa, the AI code editor, is apparently in talks to raise over$2 billion at a$50 billion valuation.

SPEAKER_00

Wait, hold up,$50 billion for a code editor? That's more than most Fortune 500 companies. I mean I know enterprise growth is strong, but that valuation seems absolutely wild to me.

SPEAKER_01

I had the same reaction. But if the numbers are real, it suggests that AI-powered development tools are being valued like infrastructure companies, not software tools. That's a massive shift in how investors are thinking about developer productivity.

SPEAKER_00

Okay, but if confirmed, this could be a signal that we're in another bubble. When code editors are worth more than established tech companies, maybe it's time to pump the brakes a little.

SPEAKER_01

Although, to be fair, if Cursor is genuinely making developers significantly more productive, and enterprise adoption is surging, like the reports suggest, maybe the economics actually work out. Developer time is expensive.

SPEAKER_00

That's true. If you can make a$200,000 per year developer 20% more productive, that's$40,000 in value per year. Multiply that across millions of developers globally, and suddenly$50 billion doesn't seem completely insane.

SPEAKER_01

Plus, A16s and Thrive are supposedly leading this round, and they're not known for throwing money at random ideas. They must see something in the enterprise traction that justifies these numbers.

SPEAKER_00

Still, I'm gonna be watching this closely.

SPEAKER_01

Speaking of anthropic, their CEO visited the White House amid concerns about hacking vulnerabilities in their new AI model. This ties back to that cybersecurity story we started with.

SPEAKER_00

Yeah, the this is all connected. The government is clearly taking AI security seriously, and companies are being called to account for potential vulnerabilities. It's like we're seeing the birth of AI national security policy in real time.

SPEAKER_01

And the fact that it's happening at the White House level suggests this isn't just regulatory theater. These are genuine concerns about AI systems being exploited for malicious purposes.

SPEAKER_00

Which makes Anthropic's cybersecurity pivot look even more strategic. They're not just solving a PR problem, they're positioning themselves as part of the solution to national security concerns.

SPEAKER_01

It also shows how quickly the relationship between AI companies and government can shift. Two months ago they were in conflict. Now the CEO is at the White House working on solutions. That's a dramatic turnaround.

SPEAKER_00

And it probably sets the template for for other companies. When you have problems with the government, you don't fight it out in public, you develop solutions that align with their priorities and take meetings at the White House.

SPEAKER_01

Right. And for any AI companies listening, this is probably the new playbook. Government relations aren't optional anymore. Core business function. You need people who understand policy and can navigate these relationships.

SPEAKER_00

Absolutely. And and the companies that figure this out early, you know, are gonna have a massive advantage. Being seen as a trusted partner by government is worth more than almost any other competitive advantage you could have.

SPEAKER_01

Meanwhile, early reports suggest Congressman Obernolta is close to releasing a draft of AI regulations, which signals that legislative efforts to govern AI are actually making progress.

SPEAKER_00

Finally, we've been talking about AI. Regulation for years, but it's mostly been academic. If Obernolte actually releases something concrete, that could be the starting gun for serious federal AI policy, federal AI.

SPEAKER_01

And the timing makes sense given everything else we're seeing. Companies are pivoting toward government-friendly positions. Security concerns are mounting, and enterprise adoption is accelerating. Regulation was inevitable.

SPEAKER_00

The question is whether it'll be thoughtful regulation that actually addresses the real risks, or just generic tech regulation with AI stamped on it.

SPEAKER_01

Given that ObanAlta has actually been engaging with the AI community and seems to understand the technology, I'm cautiously optimistic. But we'll see what's actually in the draft.

SPEAKER_00

Clear rules could actually accelerate innovation by giving companies boundaries to work within.

SPEAKER_01

Plus, if the US gets its regulatory framework right, that could become the global standard. Other countries often follow American tech policy precedents, so this draft could be really influential internationally.

SPEAKER_00

Exactly. And for any AI companies listening, now would be a good time to start engaging with policymakers. The rules are being written, and you want to have input on what they say.

SPEAKER_01

And finally, AI chipmaker Cerebrus is filing to go public after scrapping their IPO plans last year, which suggests renewed confidence in their business prospects.

SPEAKER_00

If Cerebrus thinks they can succeed in public markets, that means the demand for specialized AI chips is probably even stronger than we realized. Plus, if this IPO goes well, it could open the floodgates for other AI infrastructure companies to go public. We might be entering a new phase of market maturation.

SPEAKER_01

The timing is interesting too. Last year, when they scrapped their plans, the public markets were really hostile to tech IPOs. The fact that they're trying again suggests either their business has improved dramatically or market conditions have shifted.

SPEAKER_00

Probably both.

SPEAKER_01

Government relationships are becoming critical business assets. And specialization is replacing the one size fits all approach.

SPEAKER_00

Yeah, it's like the entire industry hit a maturation point all at once. The experimental phase is over. The prove your business model phase has begun. And honestly, that's probably healthy, even if it's less exciting than the Wild West days.

SPEAKER_01

But here's what I'm watching. As these companies get more focused on specific use cases and government relationships, are we going to see less collaboration and more competition? Because the early days of AI felt very open and collaborative.

SPEAKER_00

That's a great point. When everyone's fighting for the same enterprise contracts and government partnerships, the incentives change completely. We might be entering a much more competitive, less sharing-friendly era of AI development.

SPEAKER_01

Which could actually slow down progress overall, even if individual companies become more profitable. It's one of those classic tensions between business success and technological advancement.

SPEAKER_00

Right, but maybe that's the natural evolution of any transformative technology. The research phase gives way to the commercialization phase, which gives way to the optimization phase. We might just be witnessing that transition in real time.

SPEAKER_01

And there's another thread here around risk and safety that I think is really important. The fact that Anthropic is pivoting to cybersecurity, that their CEO is meeting with the White House, that we're getting actual AI regulation, that suggests the government is taking AI risks seriously.

SPEAKER_00

Which is probably overdue, honestly. We've had this period where AI companies were largely self-regulating. And while that enabled rapid innovation, it also created some legitimate risks that needed addressing.

SPEAKER_01

But I'm curious about the innovation implications. If companies are optimizing for government approval and enterprise sales, do we lose some of the breakthrough thinking that led to transformative capabilities in the first place?

SPEAKER_00

That's the million-dollar question. My guess is that we'll see more incremental innovation and less revolutionary leaps. But maybe that's okay. Maybe we need a period of consolidation and practical application before the next big breakthrough.

SPEAKER_01

And let's talk about the money aspect, because those valuations we discussed are just wild. Cursor at$50 billion, the AI chip IPO market opening up again. There's clearly still enormous investor appetite for AI infrastructure and tools.

SPEAKER_00

Yeah, but notice that the big money is flowing to companies with clear business models and enterprise traction. The days of funding pure research projects or consumer experiments seem to be over.

SPEAKER_01

Which brings us back to specialization. Every successful story we covered today, GPT Rosalind for Biotech, Claude Design for Business Visuals, Anthropics Cybersecurity Pivot, they're all about building AI for specific use cases.

SPEAKER_00

Exactly. The general purpose AI era is ending, and the domain-specific AI era is beginning, and that's probably better for users, even if it's less sexy from a technology perspective.

SPEAKER_01

But here's what I think is most interesting. The speed of these pivots. OpenAI shutting down entire teams, anthropic going from government conflict to White House meetings, companies completely changing strategy in a matter of months. The industry is incredibly dynamic right now.

SPEAKER_00

Which means that if you're building in this space, you need to be prepared to pivot quickly too. The companies that succeed are going to be the ones that can read market signals and adapt their strategy accordingly.

SPEAKER_01

And for anyone listening who's trying to implement AI in their business or career, the message is probably to focus on specific, measurable use cases, rather than trying to do everything with AI. The companies that are succeeding are the ones solving specific problems well.

SPEAKER_00

Totally. And honestly, that's probably more valuable to most people than the magic ever was.

SPEAKER_01

Fascinating stuff as always. And clearly we're going to have a lot to follow up on as these trends continue to develop.

SPEAKER_00

Absolutely.